Biotechnology

Regeneron Pharmaceuticals (NASDAQ: REGN): Q3 2019 Earnings Snapshot

November 5, 2019

Allergan (AGN) Q3 earnings preview: Patent issues, AbbVie deal in focus

November 3, 2019

Transcript

Immunogen Inc (NASDAQ:IMGN) Q3 2019 Earnings Call Transcript

November 1, 2019

Biogen (BIIB) Q3 profit rises 7% on spinal muscular atrophy drug addition

October 22, 2019

Biogen (BIIB) earnings preview: Will stock bounce back after Q3 report?

October 18, 2019

Pfenex shares shoot up on getting FDA approval for its osteoporosis drug

October 7, 2019

Two zero-revenue biotech stocks debut in a shaky IPO market

October 4, 2019

Will Zynerba Zygel trial be extended amid safety warning?

September 18, 2019

Alexion Pharmaceuticals could still be a valuable addition to your portfolio

September 17, 2019

Lundbeck to acquire Alder BioPharmaceuticals for $1.95 billion; Alder stock hits new 52-week high

September 16, 2019

Catalyst Pharmaceuticals stock soars to record high

September 11, 2019

Earnings preview: Market has low expectations ahead of Advaxis’ Q3 report

September 4, 2019

Johnson & Johnson tumbles on rating downgrade, after opioid ruling

August 28, 2019

Lannett stock jumps more than 15% after topping Q4 earnings and revenue estimates

August 27, 2019

Why Arbutus Biopharma stock dipped to 11-year low?

August 26, 2019

Amgen to take over Celgene’s OTEZLA for $13.4 billion; Bristol-Myers Squibb increases share buyback plan

August 26, 2019

Earnings preview: Will losses continue for Celsion in Q2

August 13, 2019

Progenics posts wider-than-expected loss in Q2

August 9, 2019

What to look for when Progenics Pharma posts Q2 earnings

August 7, 2019

Alnylam Pharmaceuticals posts narrower-than-expected Q2 loss

August 6, 2019

Transcript

Immunogen Inc (NASDAQ: IMGN) Q2 2019 Earnings Call Transcript

August 2, 2019